Interdisciplinary Approach Is Crucial to Ensure Safety in IBD and Malignancy Management


Dr Stefan Holubar from Cleveland Clinic discusses the management of inflammatory bowel disease among patients with a prior or current malignancy, which biologics and therapeutics are safe, how gastroenterologists can balance increased risk for cancer with IBD control, and more.

Stefan Holubar, MD, MS, is the Director of the IBD Multidisciplinary Team Conference at Cleveland Clinic, as well as Director of IBD Surgical Research and a colorectal surgeon at Cleveland Clinic in Ohio.

For more gastroenterology content, visit our specialty site Gastroenterology Consultant.


Published in partnership with AIBD Conference